Abstract
Fungi are common inhabitants of the oral and nasal mucosa, and therefore the differentiation between colonization and pathogenicity in the setting of upper respiratory tract infection symptoms can be difficult. Fungal head and neck infections occur in both immunocompetent and immunocompromised persons, and patients with neutropenia, diabetes mellitus, corticosteroid use, and HIV infection are particularly susceptible to serious and potentially life-threatening infections. Invasive fungal head and neck infections generally require extensive surgical debridement and prolonged systemic antifungal therapy, and frequently carry a poor prognosis when the underlying immunosuppression cannot be corrected. In contrast, noninvasive fungal head and neck infections often respond to short courses of systemic or topical antifungal therapy, or require limited surgical debridement alone.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Ascioglu S, Rex JH, de Pauw B, et al.: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34:7–14. A consensus article that provides detailed research-oriented definitions for the invasive fungal infections most often seen in immunosuppressed patients.
Rex JH, Walsh TJ, Sobel JD, et al.: Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000, 30:662–678. Detailed guidelines for the treatment of invasive and noninvasive infections caused by Candida species. Categories reflecting the strength of the recommendations and the quality of the evidence supporting the recommendations are provided.
Chapman SW, Bradsher RW Jr, Campbell GD Jr, et al.:: Practice guidelines for the management of patients with blastomycosis. Clin Infect Dis 2000, 30:679–683.
Wheat J, Sarosi G, McKinsey D, et al.: Practice guidelines for the management of patients with histoplasmosis. Clin Infect Dis 2000, 30:688–695.
Galgiani JN, Ampel NM, Catanzaro A, et al.: Practice guidelines for the treatment of coccidioidomycosis. Clin Infect Dis 2000, 30:658–661.
Stevens DA, Kan VL, Judson MA, et al.: Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000, 30:696–709. Detailed guidelines for the treatment of invasive and noninvasive infections caused by Aspergillus species. Categories reflecting the strength of the recommendations and the quality of the evidence supporting the recommendations are provided.
Dismukes WE: Introduction to antifungal drugs. Clin Infect Dis 2000, 30:653–657.
Ibekwe AO, al Shareef Z, Benayam A: Anaerobes and fungi in chronic suppurative otitis media. Ann Otol Rhinol Laryngol 1997, 106:649–652.
McDonald JA, Saulsbury FT: Chronic Candida albicans otitis media in children with immunodeficiency. Pediatr Infect Dis J 1997, 16:529–531.
Paulose KO, Khalifa SA, Shenoy P, Sharma RK: Mycotic infection of the ear (otomycosis): a prospective study. J Laryngol Otol 1989, 103:30–35.
Brooks I, Frazier EH, Thompson DH: Aerobic and anaerobic microbiology of external otitis. Clin Infect Dis 1992, 15:955–958.
Yao M, Messner AH: Fungal malignant otitis externa due to Scedosporium apiospermum. Ann Otol Rhinol Laryngol 2001, 110:377–380.
Schell WA: Unusual fungal pathogens in fungal rhinosinusitis. Otolaryngol Clin North Am 2000, 33:367–373.
Talmor M, Li P, Barie PS: Acute paranasal sinusitis in critically ill patients: guidelines for prevention, diagnosis, and treatment. Clin Infect Dis 1997, 25:1441–1446.
deShazo RD, Chapin K, Swain RE: Fungal sinusitis. N Engl J Med 1997, 337:254–259.
Ponikau JU, Sherris DA, Kern EB, et al.: The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999, 74:877–884. This paper has generated significant controversy regarding the incidence and diagnosis of allergic fungal sinusitis. Because the article has prompted such a tremendous and often harsh response, readers are encouraged to evaluate the authors’ data and conclusions first hand.
Radner AB, Witt MD, Edwards JE Jr: Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin Infect Dis 1995, 20:163–166.
Iwen PC, Rupp ME, Hinrichs SH: Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 1997, 24:1178–1184.
Stringer SP, Ryan MW: Chronic invasive fungal rhinosinusitis. Otolaryngol Clin North Am 2000, 33:375–387.
deShazo RD, O’Brien M, Chapin K: Criteria for the diagnosis of sinus mycetoma. J Allergy Clin Immunol 1997, 99:475–485.
Klossek JM, Serrano E, Peloquin L, et al.: Functional endoscopic sinus surgery and 109 mycetomas of paranasal sinuses. Laryngoscope 1997, 107:112–117.
Marple BF: Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope 2001, 111:1006–1019. A comprehensive review of the pathophysiology, clinical presentation, diagnosis, and treatment of allergic fungal sinusitis.
Schweitz LA, Gourley DS: Allergic fungal sinusitis. Allergy Proc 1992, 13:3–6.
Schubert MS, Goetz DW: Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol 1998, 102:387–394.
Schubert MS: A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 2001, 87:181–188.
deShazo RD, Swain RE: Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995, 96:24–35.
Schubert MS: Medical treatment of allergic fungal sinusitis. Ann Allergy Asthma Immunol 2000, 85:90–101.
Schubert MS, Goetz DW: Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up. J Allergy Clin Immunol 1998, 102:395–402.
Bassichis BA, Marple BF, Mabry RL, et al.: Use of immunotherapy in previously treated patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg 2001, 125:487–490.
Folker RJ, Marple BF, Mabry RL, Mabry CS: Treatment of allergic fungal sinusitis: a comparison trial of postoperative immunotherapy with specific fungal antigens. Laryngoscope 1998, 108:1623–1627.
Pindborg JJ: Classification of oral lesions associated with HIV infection. Oral Surg Oral Med Oral Pathol 1989, 26:292–295.
Glick M, Siegel MA: Viral and fungal infectious of the oral cavity in immunocompetent patients. Infect Dis Clin North Am 1999, 13:817–831.
Weinert M, Grimes RM, Lynch DP: Oral manifestations of HIV infection. Ann Intern Med 1996, 125:485–496.
Fotos PG, Vincent SD, Hellstein JW: Oral candidosis. Oral Surg Oral Med Oral Pathol 1992, 74:41.
Maenza JR, Merz WG, Romagnoli MJ, et al.: Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. J Infect Dis 1997, 24:28–34.
Schorling SR, Kortinga HC, Froschb M, Muhlschlegel FA: The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals. Crit Rev Microbiol 2000, 26:59–68.
Patton LL, Bonito AJ, Shugars DA: A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. Oral Surg Oral Med Oral Pathol 2001, 92:170–179. This paper is a comprehensive review that uses detailed inclusion and exclusion criteria of published clinical trials, and provides a summary quality score for each trial included in the final analysis.
Powderly WG, Mayer KH, Perfect JR: Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment. AIDS Res Hum Retroviruses 1999, 15:1405–1412.
Saag MS, Fessel WJ, Kaufman CA, et al.: Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients. AIDS Res Hum Retroviruses 1999, 15:1413–1417.
Fitchenbaum CJ, Zackin R, Rajicic N, et al.: Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295. AIDS 2000, 14:845–852.
Martins MD, Lozano-Chiu M, Rex JH: Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. Clin Infect Dis 1998, 27:1291–1294.
USPHS/IDSA Prevention of Opportunistic Infections Working Group: 2001 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus. Updated guidelines that are an essential resource for any physician involved in the care of HIV-infected patients. Available on the internet at http://www.hivatis.org.
Rajah V, Essa A: Histoplasmosis of the oral cavity, oropharynx, and larynx. J Laryngol Otol 1993, 107:58–61.
Bicalho RN, Santo ME, de Aguiar MC, Santos VR: Oral paracoccidioidomycosis: a retrospective study of 62 Brazilian patients. Oral Dis 2001, 7:56–60.
Myoken Y, Sugata T, Kyo T, et al.: Invasive Aspergillus stomatitis in patients with acute leukemia: report of 12 cases. Clin Infect Dis 2001, 33:1975–1980.
Denning DW: Invasive aspergillus. Clin Infect Dis 1998, 26:781–805.
Kemper CA, Hostetler JS, Follansbee SE, et al.: Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis 1993, 17:344–352.
Hanson JM, Spector G, El-Mofty SK: Laryngeal blastomycosis: a commonly missed diagnosis. Report of two cases and review of the literature. Ann Otol Rhinol Laryngol 2000, 109:281–286.
Boyle JO, Coulthand SW, Mandel RM: Laryngeal involvement in disseminated coccidioidomycosis. Arch Otolaryngol Head Neck Surg 1991, 117:433–438.
Sant’Anna GD, Mauri M, Arrarte JL, Camargo H Jr: Laryngeal manifestations of paracoccidioidomycosis (South American blastomycosis). Arch Otolaryngol Head Neck Surg 1999, 125:1375–1378.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, D.J. Diagnosis and management of Candida and other fungal infections of the head and neck. Curr Infect Dis Rep 4, 194–200 (2002). https://doi.org/10.1007/s11908-002-0078-z
Issue Date:
DOI: https://doi.org/10.1007/s11908-002-0078-z